Osteoarthritis and Bone Disorders News

Rheumatoid arthritis and fibromyalgia are among the most common comorbidities identified in patients following a diagnosis of osteoarthritis, according to data presented at the EULAR 2024 Congress.

The ability to view laboratory results, track symptoms and sharing them with a provider were rated as the most useful potential app functions by patients with rheumatic and musculoskeletal diseases, according to data.

Older adults with arthritis demonstrate poorer nutritional risk scores, and increased risks for poor nutrition, whether they have functional impairment or not, vs. those without arthritis, according to data published in Scientific Reports.

Self-administered acupressure, combined with a short education program, was a cost-effective method of pain relief that boosted mobility in adults with probable knee osteoarthritis, according to data published in JAMA Network Open.

BOSTON — The percentage of women with osteoporosis who also had diabetes increased from 2009-2010 to 2017-2018, despite a decline in overall diabetes rates for women aged 50 years and older, according to data presented at ENDO 2024.

According to published results, krill oil supplementation did not improve VAS pain scores for patients with significant knee osteoarthritis pain and effusion-synovitis compared with placebo treatment.

DESTIN, Fla. — Individualized treatment for osteoporosis calls for a keen understanding of the patient’s frame of mind, according to a speaker at the Congress of Clinical Rheumatology East.

DESTIN, Fla. — “Sprouting” of new nerve endings in certain areas of the knee could be a key to understanding osteoarthritis and developing new treatments, according to a speaker at the Congress of Clinical Rheumatology East.

DESTIN, Fla. — Patients with osteoporosis may benefit from treatment initiation with an anabolic agent followed by an antiresorptive agent, according to a speaker at the Congress of Clinical Rheumatology East.

NEW ORLEANS —Few providers conduct a complete assessment of secondary causes of osteoporosis before initiating medication, according to findings presented at the AACE annual meeting.